| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |